Stock 002424 GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Guizhou Bailing Group Pharmaceutical Co., Ltd.

Equities

002424

CNE100000PY3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-07-04 EDT 		5-day change 1st Jan Change
3.22 CNY +2.22% Intraday chart for Guizhou Bailing Group Pharmaceutical Co., Ltd. +4.21% -60.30%
07-02 Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024. CI
05-21 Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from FTSE All-World Index CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 12,348 12,292 11,050 10,622 11,404 11,236
Enterprise Value (EV) 1 13,384 13,579 12,306 11,871 12,339 12,505
P/E ratio 22.4 x 42.2 x 71.2 x 84.4 x 81.6 x -27 x
Yield 0.91% 2.53% - - - -
Capitalization / Revenue 3.94 x 4.31 x 3.58 x 3.41 x 3.22 x 2.64 x
EV / Revenue 4.27 x 4.76 x 3.99 x 3.82 x 3.49 x 2.93 x
EV / EBITDA 18.2 x 25.8 x 42.1 x 36.6 x 40.4 x -41.9 x
EV / FCF -27.4 x 67.3 x 45 x 76.4 x 27.3 x 101 x
FCF Yield -3.65% 1.49% 2.22% 1.31% 3.66% 0.99%
Price to Book 3.19 x 3.03 x 2.84 x 2.69 x 2.85 x 3.2 x
Nbr of stocks (in thousands) 1,411,200 1,411,200 1,411,200 1,397,598 1,397,598 1,385,502
Reference price 2 8.750 8.710 7.830 7.600 8.160 8.110
Announcement Date 19-04-23 20-04-29 21-04-29 22-04-22 23-04-28 24-04-29
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,137 2,851 3,088 3,112 3,540 4,263
EBITDA 1 734.3 526.4 292.4 324.2 305.6 -298.6
EBIT 1 654.4 438.2 196.5 229.5 203 -402.3
Operating Margin 20.86% 15.37% 6.36% 7.38% 5.73% -9.44%
Earnings before Tax (EBT) 1 665.8 365.7 208.8 147.8 159.1 -493.1
Net income 1 563.2 291.4 152.4 124.2 138.2 -414.5
Net margin 17.96% 10.22% 4.93% 3.99% 3.9% -9.72%
EPS 2 0.3900 0.2065 0.1100 0.0900 0.1000 -0.3000
Free Cash Flow 1 -488.1 201.8 273.2 155.3 452.1 123.2
FCF margin -15.56% 7.08% 8.85% 4.99% 12.77% 2.89%
FCF Conversion (EBITDA) - 38.34% 93.43% 47.91% 147.93% -
FCF Conversion (Net income) - 69.26% 179.28% 125.06% 327.16% -
Dividend per Share 2 0.0800 0.2200 - - - -
Announcement Date 19-04-23 20-04-29 21-04-29 22-04-22 23-04-28 24-04-29
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1,036 1,288 1,256 1,249 935 1,268
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.411 x 2.446 x 4.295 x 3.854 x 3.059 x -4.248 x
Free Cash Flow 1 -488 202 273 155 452 123
ROE (net income / shareholders' equity) 15.5% 7.27% 3.82% 2.96% 3.45% -11%
ROA (Net income/ Total Assets) 7.57% 4.2% 1.74% 2.12% 1.9% -3.53%
Assets 1 7,436 6,934 8,734 5,855 7,282 11,740
Book Value Per Share 2 2.740 2.880 2.760 2.820 2.860 2.540
Cash Flow per Share 2 0.3900 0.8100 0.7300 0.3300 0.4300 0.3000
Capex 1 129 122 90 426 68.5 104
Capex / Sales 4.11% 4.28% 2.92% 13.68% 1.93% 2.44%
Announcement Date 19-04-23 20-04-29 21-04-29 22-04-22 23-04-28 24-04-29
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD. Stock Guizhou Bailing Group Pharmaceutical Co., Ltd.
-60.30% 595M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+27.19% 5.36B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-33.59% 3.4B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
-2.97% 2.9B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-24.21% 2.53B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.11% 2.27B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+43.66% 1.84B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+46.15% 1.42B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK Stock PT Industri Jamu dan Farmasi Sido Muncul Tbk
+41.90% 1.38B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-13.92% 1.37B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 002424 Stock
  4. Financials Guizhou Bailing Group Pharmaceutical Co., Ltd.